Induction and postremission therapy: new agents
Leukemia
.
2003 Mar;17(3):496-8.
doi: 10.1038/sj.leu.2402864.
Author
R M Stone
1
Affiliation
1
Adult Leukemia Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
PMID:
12646937
DOI:
10.1038/sj.leu.2402864
No abstract available
Publication types
Address
MeSH terms
Acute Disease
Antineoplastic Agents / therapeutic use*
Drug Delivery Systems
Humans
Leukemia, Myeloid / drug therapy*
Remission Induction / methods
Substances
Antineoplastic Agents